Cargando…
Molecular and clonal evolution in vivo reveal a common pathway of distant relapse gliomas
The evolutionary trajectories of genomic alterations underlying distant recurrence in glioma remain largely unknown. To elucidate glioma evolution, we analyzed the evolutionary trajectories of matched pairs of primary tumors and relapse tumors or tumor in situ fluid (TISF) based on deep whole-genome...
Autores principales: | Liu, Guanzheng, Bu, Chaojie, Guo, Guangzhong, Zhang, Zhiyue, Sheng, Zhiyuan, Deng, Kaiyuan, Wu, Shuang, Xu, Sensen, Bu, Yage, Gao, Yushuai, Wang, Meiyun, Liu, Gang, Kong, Lingfei, Li, Tianxiao, Li, Ming, Bu, Xingyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462858/ https://www.ncbi.nlm.nih.gov/pubmed/37649695 http://dx.doi.org/10.1016/j.isci.2023.107528 |
Ejemplares similares
-
Genomic alterations of oligodendrogliomas at distant recurrence
por: Liu, Guanzheng, et al.
Publicado: (2023) -
Real‐time longitudinal analysis of human gliomas reveals in vivo genome evolution and therapeutic impact under standardized treatment
por: Xu, Sensen, et al.
Publicado: (2022) -
Tumor DNA From Tumor In Situ Fluid Reveals Mutation Landscape of Minimal Residual Disease After Glioma Surgery and Risk of Early Recurrence
por: Yu, Jinliang, et al.
Publicado: (2021) -
Integrating real‐time in vivo tumour genomes for longitudinal analysis and management of glioma recurrence
por: Sheng, Zhiyuan, et al.
Publicado: (2021) -
Tracking tumor evolution during the first-line treatment in brain glioma via serial profiling of cell-free tumor DNA from tumor in situ fluid
por: Sheng, Zhiyuan, et al.
Publicado: (2023)